Results 111 to 120 of about 333,858 (264)

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Retracted: Broadband Design of Midinfrared Chiral Metamaterials Based on the Indium Tin Oxide Conical Helix

open access: yesInternational Journal of Analytical Chemistry, 2023
International Journal of Analytical Chemistry
doaj   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Retracted: Application of Calcium-Based Nanomaterials in Art Sculpture Reinforcement Technology

open access: yesInternational Journal of Analytical Chemistry, 2023
International Journal of Analytical Chemistry
doaj   +1 more source

Editorial: Women in Analytical Chemistry. [PDF]

open access: yesFront Chem, 2022
Jaffrezic-Renault NJ   +4 more
europepmc   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

open access: yesMolecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard   +12 more
wiley   +1 more source

Retracted: Application of Isotope Tracer in Cross-Well Nanometre Tracer Testing

open access: yesInternational Journal of Analytical Chemistry, 2023
International Journal of Analytical Chemistry
doaj   +1 more source

Home - About - Disclaimer - Privacy